Since CD8+ T cell exhaustion and Treg cell development in tissues are both critical in regulating tumor and infection progression, targeting these top master regulators could help relieve these diseases and open the door for new combinational immunotherapies using current checkpoint blockade strategies. The gene discussed is CD8A; the disease is infection.